학술논문

Paediatric patients with heterozygous familial hypercholesterolaemia treated with evolocumab for 80 weeks (HAUSER-OLE): a single-arm, multicentre, open-label extension of HAUSER-RCT
Document Type
Article
Source
In The Lancet Diabetes & Endocrinology October 2022 10(10):732-740
Subject
Primary Research
Articles
Language
ISSN
2213-8587